EMVision Medical Devices Ltd (EMV.XA)
- Previous Close
1.8700 - Open
1.8800 - Bid --
- Ask --
- Day's Range
1.8800 - 1.8850 - 52 Week Range
1.1200 - 2.7300 - Volume
466 - Avg. Volume
22,473 - Market Cap (intraday)
-- - Beta (5Y Monthly) 1.61
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1000 - Earnings Date Jul 25, 2024 - Jul 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
EMVision Medical Devices Ltd engages in the research, development, and commercialization of imaging and diagnostic technology products. It develops a portable brain scanner for stroke diagnosis and monitoring, as well as other medical imaging needs. The company was incorporated in 2017 and is based in Macquarie Park, Australia.
www.emvision.com.au--
Full Time Employees
June 30
Fiscal Year Ends
--
Sector
--
Industry
Recent News: EMV.XA
Performance Overview: EMV.XA
Trailing total returns as of 6/2/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EMV.XA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EMV.XA
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-37.17%
Return on Assets (ttm)
-16.10%
Return on Equity (ttm)
-47.66%
Revenue (ttm)
8.68M
Net Income Avi to Common (ttm)
-3.22M
Diluted EPS (ttm)
-0.1000
Balance Sheet and Cash Flow
Total Cash (mrq)
8.48M
Total Debt/Equity (mrq)
52.07%
Levered Free Cash Flow (ttm)
-2.06M